Skip to search.
 TSX Down 0.49% TSX Ventures Down 2.16%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc. (TTH.TO)

-Toronto
2.02 0.00(0.00%) Aug 23, 9:53AM EDT
Prev Close:2.02
Open:2.05
Bid:1.98
Ask:2.05
1y Target Est:N/A
Beta:2.54551
Earnings Date:Sep 13 - Sep 19 (Est.)
Day's Range:2.02 - 2.05
52wk Range:0.89 - 3.54
Volume:700
Avg Vol (3m):14,544
Market Cap:78.37M
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :N/A
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback